# Intranasal Dexmedetomidine for Prevention of Intrapartum Fever

> **NCT07501221** · NA · NOT_YET_RECRUITING · sponsor: **Chengdu Jinjiang Maternity and Child Health Hospital** · enrollment: 446 (estimated)

## Conditions studied

- Intrapartum Fever

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07501221
- **Lead sponsor:** Chengdu Jinjiang Maternity and Child Health Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 446 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07501221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07501221, "Intranasal Dexmedetomidine for Prevention of Intrapartum Fever". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07501221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*